Shandong Weigao Group Medical Polymer Company Limited SHWGF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.94B | 1.90B | 1.86B | 1.84B | 1.82B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.94B | 1.90B | 1.86B | 1.84B | 1.82B |
| Cost of Revenue | 1.06B | 1.02B | 983.03M | 949.41M | 919.40M |
| Gross Profit | 886.38M | 881.84M | 880.02M | 886.33M | 895.75M |
| SG&A Expenses | 537.21M | 534.07M | 532.42M | 516.63M | 502.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.69B | 1.64B | 1.61B | 1.56B | 1.51B |
| Operating Income | 258.66M | 256.98M | 256.26M | 279.22M | 302.97M |
| Income Before Tax | 263.50M | 272.41M | 282.13M | 307.85M | 334.50M |
| Income Tax Expenses | 52.30M | 48.35M | 44.61M | 46.29M | 48.13M |
| Earnings from Continuing Operations | 211.21 | 224.05 | 237.52 | 261.56 | 286.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.66M | -13.66M | -13.71M | -13.67M | -13.68M |
| Net Income | 197.55M | 210.39M | 223.82M | 247.89M | 272.69M |
| EBIT | 258.66M | 256.98M | 256.26M | 279.22M | 302.97M |
| EBITDA | 391.30M | 386.12M | 382.33M | 407.85M | 434.61M |
| EPS Basic | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 |
| Normalized Basic EPS | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
| EPS Diluted | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 |
| Normalized Diluted EPS | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
| Average Basic Shares Outstanding | 18.10B | 18.12B | 18.14B | 18.18B | 18.23B |
| Average Diluted Shares Outstanding | 18.12B | 18.13B | 18.15B | 18.21B | 18.27B |
| Dividend Per Share | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Payout Ratio | 70.39% | 66.10% | 62.13% | 52.32% | 44.49% |